MRS metabolic markers of seizures and seizure-induced neuronal damage

Epilepsia

Volumn 39, Issue 3, 1998, Pages 244-250

  Najm, I M ^a   Wang, Y ^a   Shedid, D ^a   Luders H O ^a   Ng, T C ^a   Comair, Y G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cycloheximide; Hippocampus; Kainic acid; Seizure; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; CYCLOHEXIMIDE; KAINIC ACID; LACTIC ACID; N ACETYLASPARTIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN; CELL COUNT; CHOLINE; CREATINE; CYCLOHEXIMIDE; HIPPOCAMPUS; KAINIC ACID; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; STATUS EPILEPTICUS;

EID: 0031936837     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01368.x     Document Type: Article

References (48)

1. Ebisu T, Rooney W, Graham S, Weiner M, Maudsley A. NAcetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 1994;14:373-82.
2. Meric P, Barrere B, Peres M, et al. Effects of kainate-induced seizures on cerebral metabolism: a combined 1H and 3 IP NMR study in rat. Brain Res 1994;638:53-60.
3. Najm I, Wang Y, Hong SC, Lüders HO, Ng T, Comair Y. Temporal changes in proton MRS metabolites after kainic acid-induced seizures in rat brain. Epilepsia 1997;38:87-94.
4. Falconer MA, Seragetinides EA, Corsellis JAN. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233-43.
5. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes; a clinical encephalographice and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
6. Brown WJ, Structural substrate of seizures foci in the human temporal lobe. In: Brazier MAB, ed. Epilepsy; its phenomenon in man. New York: Academic Press, 1973:339-47.
7. Scheibel ME, Scheibel AB. Hippocampal pathology in temporal lobe epilepsy: a Golgi survey. In: Brazier MAB, ed. Epilepsy: its phenomenon in man. New York: Academic Press, 1973;311-21.
8. Scheibel ME. Crandall PH, Scheibel AB. The hippocampal-dentate complex in temporal lobe epilepsy: a Golgi study. Epilepsia 1974;15:15-22.
9. Dam AM. Epilepsy and neuronal loss in the hippocampus. Epilepsia 1980;21:617-23.
10. Schwob JE, Fuller T, Price JL, Olney JW. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 1980;5:991-1014.
11. Lothman EW, Collins RC. Kainic acid-induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 1981;218:299-318.
12. Nitecka LE, Tremblay G, Charton JP, Bouillot ML, Berger, BenAri Y. Maturation of kainic acid seizure brain damage syndrome in the rat. II-histopathological sequelae. Neuroscience 1984;13: 1073-94.
13. Ben-Ari Y, Represa A, Tremblay E, Nitecka L. Selective and non-selective seizure related brain damage produced by kainic acid. Adv Exp Med Biol 1986;203:647-57.
14. Najm I, El-Skaf G, Massicotte G, Vanderklish P, Lynch G, Baudry M. Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of Difluoromethylornithine. Exp Neurol 1992;116:345-54.
15. Pollard H, Charriaut-Marlangue C, Cantragrel S, et al. Kainate-induced apoptotic cell death in hippucampal neurons. Neuroscience 1994;63:7-18.
16. Dugich-Djordjevic M, Tocco G, Lapchak PA, et al. BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity. Neuron 1992;8:1127-38.
17. Schreiber SS, Tocco G, Najm I, Finch CE, Johnson SA, Baudry M. Absence of c-fos induction in neonatal rat brain after seizures. Neurosci Lett 1992;136:31-5.
18. Schreiber SS, Najm I, Tocco G, Baudry M. Co-expression of HSP72 and c-fos in rat brain following kainic acid treatment. Neurorepon 1993;5:269-72.
19. Pennypacker KR, McMillian MK, Douglass J, Hong JS. Ontogeny of kainate induced gene expression in rat hippocampus. J Neurochem 1994;62:438-44.
20. Schreiber SS, Tocco G, Najm I, Thompson RF, Baudry M. Cycloheximide prevents kainate-induced neuronal death and c-fos expression in adult rat brain. J Molec Neurosci 1993;4:149-59.
21. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber S. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 1994;91:7525-9.
22. Smeyne RJ, Vendrell M, Hayward M, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363:166-9.
23. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgicul localization with proton chemical shift imaging. Radiology 1994;193:465-72.
24. Comair Y, Ng T, Xue M, et al. Early postictal lactate detection in temporal lobe epilepsy for localization of seizure focus: a proton chemical shift imaging study [Abstract]. Proc 2nd Soc Mag Res 1994, 1994;1:401.
25. de-Vera N, Artigas F, Serratosa J, Martinez E. Changes in polyamine levels in rat brain after systemic kainic acid administration: relationship to convulsant activity and brain damage. J Neurochem 1991;57:l-8.
26. Hong SC, Goto Y, Lanzino G, Soleau S, Kassell NF, Lee KS. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 1994;25:663-9.
27. Schneider HJ, Dullenkopf P. Slotted tube resonator: a new NMR probe head at high observing frequency. Rev Sci Instrum 1977;48: 68-73.
28. Petroff OAC, Ogino T, Alger JR. High resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolites levels and post-mortem changes. J Neurochem 1988;51:163-71.
29. Gill SS, Thomas DOT, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504.
30. Harding VJ, Eagles BA. The creatine content of brain. J Biol Chem 1924;60:301-10.
31. Ben-Ari Y, Tremblay E, Riche D, Ghillini GR, Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentylenetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 1981;6:1361-91.
32. Tremblay E, Ben-Ari Y. Usefulness of parenteral kainic acid as a model of temporal lobe epilepsy. Rev EEC Neurophysiol 1984;14: 241-51.
33. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann Rev Neurosci 1991;14:421-51.
34. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987:508:333-48.
35. Haase A, Fraham J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-4.
36. Curran T, Morgan JI. Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995;26:403-12.
37. Moffett JR, Namboodiri MAA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 199l;2:131-4.
38. Meyerhoff JL, Carter RE, Yourick DL, Slusher BS, Coyle JT. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate. Brain Res 1992;593:140-3.
39. 1H magnetic resonance study. Ann NY Acad Sci 1987;508:54-63.
40. 1H spectroscopy of the human brain following electroconvulsive therapy. Ann Neurol 1990;28:745-9.
41. Matthews BS, Andermann F, Arnold DL. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 1990;40:985-9.
42. During MJ, Fried I, Leone P, Katz A, Spencer D. Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. J Neurochem 1994;62:2356-61.
43. Ackerman RF, Lear JL. Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxy-glucose and glucose. J Cereb Blood Flow Metab 1989;9:774-85.
44. Franck G, Sadzot B, Salmon E. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus, Adv Neurol 1986;44:935-48.
45. Ingvar M. Cerebral blood flow and metabolic rate during seizures. Ann NY Acad Sci 1986;462:194-206.
46. Siesjo BK. Brain metabolism. New York: John Wiley and Son, 1978.
47. Siesjo BK, Ingvar M, Wieloch T. Cellular and molecular events underlying epileptic brain damage. Ann NY Acad Sci 1986;462: 207-23.
48. McGregor IS, Menendez JA, Atrenz DM. Metabolic effects obtained from excitatory amino acid stimulation of the sulcal prefrontal cortex. Brain Res 1990;529:1-6.